Genesis Healthcare, Inc. (NYSE:GEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ME Staff 8-k
Genesis Healthcare, Inc. (NYSE:GEN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 29, 2017, Glenn S. Schafer, a Class III director of Genesis Healthcare Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision not to stand for re-election when his term expires at the Company’s 2017 Annual Meeting of Stockholders to be held on June 7, 2017. Mr. Schafer will continue to serve on the Board until the annual meeting. Mr. Schafer’s decision not to stand for re-election was the result of his desire to reduce his travel and business commitments and was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
About Genesis Healthcare, Inc. (NYSE:GEN) Genesis Healthcare, Inc., formerly Skilled Healthcare Group, Inc., is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services. It offers inpatient services through its network of over 500 skilled nursing and assisted/senior living facilities in 34 states, consisting of over 475 skilled nursing facilities and over 35 stand-alone assisted/senior living facilities. Its skilled nursing and assisted/senior living facilities have over 61,000 licensed beds, with its states of operation in California, Maryland, Massachusetts, New Jersey, and Pennsylvania. Genesis Healthcare, Inc. (NYSE:GEN) Recent Trading Information Genesis Healthcare, Inc. (NYSE:GEN) closed its last trading session down -0.03 at 2.53 with 143,748 shares trading hands.